Hong Kong Exchanges and Clearing : APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

SOLIS HOLDINGS LIMITED

守 益 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2227)

APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

The Board hereby announces that Dr. Guan Huan Fei 關浣非 (''Dr. Guan'') has been appointed as an independent non-executive Director of the Company with effect from 23 August 2019. The biographical details of Dr. Guan are a follows:

Dr. Guan, aged 63, has extensive experience in the finance and insurance industry in Hong Kong and the People's Republic of China. He held various senior managerial positions in the People's Insurance Company of China (Jilin Branch) (中國人民保險公司吉林省分公司), the business department of Hong Kong and Macao Regional Office of China Insurance Group (中國保險港澳管理處), Ming An Insurance Company (Hong Kong) Limited (香港民安保險有限公司) and China Pacific Insurance Co., (HK) Ltd. (中國太平洋保險（香港）有限公司). He also held offices at the Bank of Communications, including the deputy chairman of the risk asset management committee, deputy chairman of credit asset management, chairman of loan verification committee, deputy general manager of the Bank of Communications Hong Kong Branch, the director of Bank of Communications Trustee Limited, the chairman and chief executive of China BOCOM Insurance Co., Ltd. and an executive director and general manager of BoComm Life Insurance Company Limited.

Dr. Guan is also currently an independent non-executive director for each of China Nonferrous Mining Corporation Limited (1258.HK), HongDa Financial Holding LTD (1822.HK), China Shandong Hi- Speed Financial Group Limited (412.HK), Huarong International Financial Holdings Limited (0993.HK) and Sunwah Kingsway Capital Holdings Limited (0188.HK).

- 1 -

Dr. Guan was appointed as a non-executive director of Ping An Securities Group (Holdings) Limited (0231.HK) for the period from December 2017 to June 2018. Dr. Guan had been the chairman emeritus of Culturecom Holdings Limited (0343.HK) (a company listed on the Main Board of the Stock Exchange) and the chairman of the board of directors of UCAN.COM Group Limited, a subsidiary of Culturecom Holdings Limited from July 2013 to March 2016. Dr. Guan has been an executive director of CCT Land Holdings Limited (0261.HK) since May 2015 and had resigned in September 2017. Dr. Guan was an independent non-executive director of Silver Base Group Holdings Limited (0886.HK) (a company listed on the Main Board of the Stock Exchange) for the period from March 2008 to January 2011. He was an executive director and president of the said company from January 2011 to December 2012.

Dr. Guan obtained a doctor's degree in Economics in 2000 from Wuhan University and was a postdoctoral researcher in Theoretical Economics with Fudan University from 2000 to 2002. Dr. Guan has been a part-time researcher of the Insurance Research Centre of Fudan University since 2004. He has been appointed as a part-time lecturer of a professional degree of Fudan University since 2013. Dr. Guan is an economic and technical consultant of Jilin Provincial Government.

Dr. Guan has signed a letter of appointment with the Company for a term of 1 year with an annual director's fee of HK$240,000, which was determined with reference to his duties and responsibilities, the Company's remuneration policy, the prevailing market conditions and recommendations of the remuneration committee of the Board (''Remuneration Committee''). Dr. Guan's remuneration will be subject to annual review by the Remuneration Committee and the Board from time to time with reference to his responsibility and performance.

Dr. Guan shall hold office until the next general meeting of the Company and will be eligible for and subject to re-election at such meeting in accordance with the Articles of Association of the Company.

Save as disclosed in this announcement, Dr. Guan does not hold any other position in the Company or its subsidiaries nor any directorship in other listed public company in the last three years.

Dr. Guan does not have any relationship with any directors, senior management, substantial or controlling shareholders (as defined under the Listing Rules) of the Company.

Further, Dr. Guan does not have, and is not deemed to have, any interests or short positions in any shares, underlying shares or debentures (within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong)) of the Company as at the date of this announcement.

Save as disclosed above, there was no matter relating to the appointment of Dr. Guan that needs to be brought to the attention of the shareholders and there is no other information which is required to be disclosed pursuant to any requirements of Rules 13.51(2)(h) to (v) of the Listing Rules and Dr. Guan meets the independence guidelines set out in rule 3.13 of the Listing Rules.

- 2 -

The Board would like to express its warmest welcome to Dr. Guan on his appointment.

By Order of the Board

Solis Holdings Limited

Tay Yong Hua

Executive Chairman and Executive Director

Singapore, 23 August 2019

As at the date of this announcement, the executive Directors are Mr. Tay Yong Hua, Mr. Tay Yong Meng and Mr. Kenneth Teo Swee Cheng (Kenneth Zhang Ruiqing); the independent non-executive Directors are Ms. Theng Siew Lian Lisa, Mr. Tan Sin Huat Dennis, Mr. Cheung Garnok and Dr. Guan Huan Fei.

- 3 -